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Introduction
In order to evaluate pharmacokinetic variability of pre-
ventive migraine drugs we have in this study reviewed
single dose studies.
Methods
PubMed was searched for each drug with the “drugs
generic name”, “pharmacokinetics”, and “single dose”.
Variability was calculated as coefficient of variation (CV).
Results
A total of 105 single-dose kinetic studies were reviewed
but only a few representative results are presented:
Extended release propranolol 160 mg (n = 2): CV for
Cmax = 45-55%, and CV for AUC: 43-48%. Propranolol
80 mg (n =1): Ratio for Cmax = 14 and ratio for AUC =
24. Metoprolol 100 mg (n = 2): CV for Cmax = 23-64%,
and CV for AUC: 26-75%. Metoprol 100 mg (n = 1): Ratio
for Cmax = 8 and ratio for AUC = 23. Extended release
divalproex 500 and 1000 mg (n = 2): CV for Cmax = 12-
21%, and CV for AUC: 19-30%. Topiramate 100 mg
(n = 1): CV for Cmax = 16% and CV for AUC = 14%..
Candesartan 16 mg (n =2) : CV for Cmax = 31-34% and
CV for AUC 26-28%.
Conclusion
A coefficient of variation of a pharmacokinetic para-
meter above 40% is considered to be high . The results
for the AUCs of propranolol and metoprolol show high
variability; and it is not likely that the migraine patients
can be treated with a fixed dose-schedule with these
two drugs. Instead dosing should in each case be
tailored to the individual migraine patients.
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